Nevertheless, the expression of ER, aromatic enzymes, and estrogen-related effects in the TME have shown that estrogen can also promote the progression of malignant tumors through immunosuppression (44), and other mechanisms, such as angiogenesis, hypoxia, and inflammation (45). Here, ESR1 is linked to cancer.